You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
None
An entertaining guide to the most eccentric characters from British history
None
Noted textile designer and lichen expert explains how to create and use dyes derived from lichens. Text covers history of the use of lichen pigments, safe dyeing methods, ecologically sound dyeing, and use of mordants, lichen identification, and more. Text also offers a fascinating history of Asian and European lichen pigments, Scottish, Irish, and Scandinavian domestic lichen dyes, and others.
List of fellows in v. 1-5, 7-16, 20-30, 32-33, 35-41, 45; continued since 1908 in the Proceedings, v. 28-
This book is open access under a CC BY 4.0 license. This book breaks new ground by situating animals and their diseases at the very heart of modern medicine. In demonstrating their historical significance as subjects and shapers of medicine, it offers important insights into past animal lives, and reveals that what we think of as ‘human’ medicine was in fact deeply zoological. Each chapter analyses an important episode in which animals changed and were changed by medicine. Ranging across the animal inhabitants of Britain’s zoos, sick sheep on Scottish farms, unproductive livestock in developing countries, and the tapeworms of California and Beirut, they illuminate the multi-species dimensions of modern medicine and its rich historical connections with biology, zoology, agriculture and veterinary medicine. The modern movement for One Health – whose history is also analyzed – is therefore revealed as just the latest attempt to improve health by working across species and disciplines. This book will appeal to historians of animals, science and medicine, to those involved in the promotion and practice of One Health today.
Six decades after the serendipitous discovery of chlorpromazine as an antipsychotic and four decades after the launch of clozapine, the first atypical or second generation antipsychotic, psychopharmacology has arrived at an important crossroad. It is clear that pharmacological research and pharmaceutical development must now focus on complementary or even alternative mechanisms of action to address unmet medical needs, i.e. poorly treated domains of schizophrenia, improved acceptance by patients, better adherence to medication, safety in psychoses in demented patients, and avoiding cardiac and metabolic adverse effects. The first completely novel mechanisms evolving from our insights into th...